{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:59:56Z","timestamp":1740146396249,"version":"3.37.3"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Municipal Natural Science Foundation (CN)","award":["7173277"],"award-info":[{"award-number":["7173277"]}]},{"name":"the National Science and Technology Major Projects","award":["2012ZX10002006"],"award-info":[{"award-number":["2012ZX10002006"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0207431","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T19:43:25Z","timestamp":1542311005000},"page":"e0207431","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines"],"prefix":"10.1371","volume":"13","author":[{"given":"Hui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9660-0216","authenticated-orcid":true,"given":"Changgui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO tables 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/influenza\/human_animal_interface\/2017_10_30_tableH5N1.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/influenza\/human_animal_interface\/2017_10_30_tableH5N1.pdf<\/ext-link>."},{"key":"ref2","unstructured":"World Health Organization. Latest risk assessment summary of influenza at the human\u2013animal interface 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/influenza\/human_animal_interface\/Influenza_Summary_IRA_HA_interface_10_30_2017.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/influenza\/human_animal_interface\/Influenza_Summary_IRA_HA_interface_10_30_2017.pdf<\/ext-link>."},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(17)30240-2","article-title":"Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A\/17\/turkey\/Turkey\/05\/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial","volume":"17","author":"P Pitisuttithum","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1473-3099(15)00266-2","article-title":"High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial","volume":"15","author":"D Liebowitz","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3181\/00379727-100-24582","article-title":"Cytopathogenic effect produced by polyoma virus in cultures of milk-adapted murine lymphoma cells (strain P388 D1)","volume":"100","author":"AS Rabson","year":"1959","journal-title":"Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.vaccine.2011.11.019","article-title":"Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard","volume":"30","author":"JM Wood","year":"2012","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/1471-2334-10-338","article-title":"A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults","volume":"10","author":"H Nagai","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1128\/CVI.00278-15","article-title":"International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE","volume":"22","author":"KL Laurie","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"T Rowe","year":"1999","journal-title":"J CLIN MICROBIOL"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0264-410X(89)90045-5","article-title":"Fluorometric assay for the measurement of viral neuraminidase in influenza vaccines","volume":"7","author":"CR Lambre","year":"1989","journal-title":"Vaccine"},{"key":"ref11","article-title":"Haemagglutination inhibition test","author":"DW Palmer DF","year":"1975","journal-title":"Health, Education, and Welfare"},{"issue":"24","key":"ref12","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1056\/NEJMoa073121","article-title":"A clinical trial of a whole-virus H5N1 vaccine derived from cell culture","volume":"358","author":"HJ Ehrlich","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1128\/JCM.32.4.987-990.1994","article-title":"Neutralization enzyme immunoassay for influenza virus","volume":"32","author":"CA Benne","year":"1994","journal-title":"Journal of Clinical Microbiology"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1096-9071(199805)55:1<82::AID-JMV13>3.0.CO;2-1","article-title":"Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay","volume":"55","author":"EJ Remarque","year":"1998","journal-title":"J Med Virol"},{"issue":"20","key":"ref15","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2007.02.039","article-title":"Comparison of neutralising antibody assays for detection of antibody to influenza A\/H3N2 viruses: an international collaborative study","volume":"25","author":"I Stephenson","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jviromet.2004.07.005","article-title":"Neuraminidase activity assays for monitoring MDCK cell culture derived influenza virus","volume":"122","author":"DP Nayak","year":"2004","journal-title":"J Virol Methods"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1743-422X-5-109","article-title":"Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay","volume":"5","author":"MC Eichelberger","year":"2008","journal-title":"Virol J"},{"issue":"1\u20132","key":"ref18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2004.02.019","article-title":"Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A\/Duck\/Singapore\/97 vaccine","volume":"103","author":"I Stephenson","year":"2004","journal-title":"Virus Res"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.vaccine.2009.10.066","article-title":"A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses","volume":"28","author":"A Hassantoufighi","year":"2010","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0207431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T09:24:08Z","timestamp":1605432248000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0207431"}},"subtitle":[],"editor":[{"given":"Victor C.","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0207431","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,11,15]]}}}